Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -3.20 (-3.10%)
Bid:
100.40
Ask:
102.00
Spread: 1.60 (1.594%)
Market Cap: £163.94m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

8 Nov 2012 07:00

RNS Number : 6049Q
Yule Catto & Co PLC
08 November 2012
 



YULE CATTO & CO PLC

 

INTERIM MANAGEMENT STATEMENT

 

Continued resilient performance; Intention to change Group name

 

Yule Catto & Co plc ("Yule Catto" or "the Group") today issues its interim management statement for the period 1 July to 8 November 2012. The Group also announces its intention to change its name to Synthomer plc.

 

Trading

 

The Group has continued to perform in line with the Board's expectations since the last update provided at the interim results in August, despite the challenging macro-economic conditions, particularly in Europe.

 

In Europe and North America, profit to date remains well ahead of prior year. This has been achieved notwithstanding year to date volumes down 10%, and an adverse translation impact of £4.5 million in the first nine months of the year due to the weaker euro. This performance reflects the continued benefits of good margin management and synergy delivery which the Group has achieved during the period. Demand remains subdued with construction related areas continuing to be particularly affected. 

 

In Asia and ROW, the non-nitrile businesses continued the positive momentum achieved in the first half. Our Nitrile business is trading in line with the guidance provided at the interim results.

 

We continue to make strong progress with synergy delivery from the PolymerLatex acquisition, and remain firmly on track to realise £19 million of synergies in the current year, a year on year improvement of £16 million. The Group continues to expect to deliver the total £25 million of targeted annual synergies by March 2013. 

 

The Group's financial position remains robust with net debt at the end of September at £160 million, down from £174 million at the half year.

 

Outlook

 

The Board's expectations remain unchanged from those stated at the half year. Full year underlying profit before tax is expected to be ahead of 2011 pro-forma of £96 million.

 

Intention to change Group name to Synthomer plc

 

Over the last 5 years the Group has been transformed from a small, diversified chemical business, of which Yule Catto was the holding company, to a much larger, focussed speciality polymer business. The Group trades under the name Synthomer across the majority of its business, and the Board has therefore decided that now is an appropriate time to reflect this in the Group's name.

 

The Group will convene an Extraordinary General Meeting in on December 4 where shareholders will be asked to approve this change. If shareholders agree to this proposal, the Group's name will be changed to Synthomer plc before the year end. A circular to this effect will be distributed to shareholders today.

 

Commenting Adrian Whitfield, Group Chief Executive, said:

 

"We are pleased to have delivered a resilient performance in difficult market conditions. The Group's strong portfolio of products and leading market positions provide an excellent platform for growth and we remain confident of continuing to deliver value for our shareholders."

 

Enquiries:

 

Adrian Whitfield, Group Chief Executive

Charles Armitstead / Rosie Oddy

David Blackwood, Group Finance Director

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

 

The company will host a conference call for analysts at 8.00am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFFALLLDIIF
Date   Source Headline
3rd May 20181:38 pmRNSHolding(s) in Company
2nd May 20184:29 pmRNSDirector/PDMR Shareholding
26th Apr 20182:23 pmRNSResult of AGM
26th Apr 20187:00 amRNSQ1 Trading update
9th Apr 20184:54 pmRNSDirector Declaration
27th Mar 20181:03 pmRNSDirector/PDMR Shareholding
27th Mar 20181:01 pmRNSDirector/PDMR Shareholding
26th Mar 20184:55 pmRNSAnnual Financial Report
8th Mar 20184:39 pmRNSDirector/PDMR Shareholding
8th Mar 20184:37 pmRNSDirector/PDMR Shareholding
5th Mar 20182:43 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSResults for the year ended 31 December 2017
12th Feb 201810:27 amRNSDirector Declaration
1st Feb 20187:00 amRNSCompletion of the acquisition of BASF Pischelsdorf
2nd Jan 20187:00 amRNSDisposal of Synthomer Leuna Gmbh facility
13th Dec 20172:55 pmRNSDirector Declaration
4th Dec 20175:31 pmRNSHolding(s) in Company
27th Nov 20179:29 amRNSHolding(s) in Company
10th Nov 20179:40 amRNSDirectorate Change
9th Nov 201710:03 amRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSQ3 Trading update
9th Oct 20179:23 amRNSDirector Declaration
28th Sep 20177:00 amRNSAcquisition of BASF Pischelsdorf
18th Sep 20172:00 pmRNSHolding(s) in Company
17th Aug 201712:54 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSInterim Results for the 6 months ended 30 Jun 2017
1st Aug 20173:57 pmRNSHolding(s) in Company
10th Jul 201710:33 amRNSDirector/PDMR Shareholding
9th Jun 20173:14 pmRNSDirector/PDMR Shareholding
8th May 201712:40 pmRNSDirector/PDMR Shareholding
8th May 201712:24 pmRNSDirector/PDMR Shareholding
27th Apr 20174:05 pmRNSDirector Declaration
27th Apr 20172:53 pmRNSResult of AGM
27th Apr 20177:00 amRNSQ1 Trading update
27th Mar 20179:54 amRNSAnnual Financial Report
6th Mar 20177:02 amRNSAcquisition of Perstorp Belgium
6th Mar 20177:00 amRNSFinal Results
23rd Feb 20174:31 pmRNSAmendment TR-1 notification
8th Feb 20174:13 pmRNSHolding(s) in Company
6th Feb 201711:48 amRNSHolding(s) in Company
20th Jan 20177:00 amRNSQ4 and FY trading update
13th Dec 201610:57 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSCapital Markets Day
28th Nov 20169:51 amRNSHolding(s) in Company
18th Nov 20164:56 pmRNSHolding(s) in Company
16th Nov 201610:15 amRNSHolding(s) in Company
10th Nov 20162:23 pmRNSHolding(s) in Company
9th Nov 20164:18 pmRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSQ3 Trading update
3rd Oct 20162:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.